Alstead, E. M., Wilson, A. G., Farthing, M. J. (1991) Lichen planus and mesalazine. Journal of Clinical Gastroenterology 13 (3): 335–337.
Brimblecombe, R. (1990) Mesalazine: a global safety evaluation. Scandinavian Journal of Gastroenterology 25 (suppl 172): 66–68.
Fardy, J. M., Lloyd, D. A., Reynolds, R. P. (1988) Adverse effects with oral 5-aminosalicylic acid. Journal of Clinical Gastroenterology 10 (6): 635–637.
Hadjigogos, K. (1991) Unusual side effects of mesalazine. Italian Journal of Gastroenterology 23: 257.
Masson, E. A., Rhodes, J. M. (1992) Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss. Gut 33 (4): 563–564.
Pent, M. T., Ganapathy, S., Holdsworth, C. D., Channer, K. C. (1992) Mesalazine induced lupus like syndrome. British Medical Journal 305: 159.
Pullar, T. (1992) Adverse effects of sulphasalazine. Adverse Drug Reaction and Toxicological Reviews 11 (2): 93–109.
Reinoso, M. A., Schroeder, K. W., Pisani, R. J. (1992) Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest 101 (5): 1469–1471.
Ruderman, W. B. (1990) Newer pharmacologic agents for the therapy of inflammatory bowel disease. Medical Clinics of North America 74 (1): 133–153.